Cytomx Patient Enrolled Equipment & Supplies

1 equipment items found

CytomX - Model BMS-986288 - CTLA-4-Directed Probody Therapeutic

Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)

Bristol Myers Squibb is enrolling patients in the dose escalation phase of a Phase 1/2a clinical trial (NCT03994601) of a second anti-CTLA-4 Probody, BMS-986288, based on a modified version of Yervoy® (ipilimumab), to evaluate a CTLA-4-directed Probody therapeutic alone or in combination with Opdivo® (nivolumab) in patients with selected ...

CONTACT SUPPLIER

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you